A detailed history of Monaco Asset Management Sam transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Monaco Asset Management Sam holds 3,850,920 shares of GOSS stock, worth $2.7 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
3,850,920
Previous 2,726,104 41.26%
Holding current value
$2.7 Million
Previous $2.45 Million 55.4%
% of portfolio
0.57%
Previous 0.4%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$0.79 - $1.25 $888,604 - $1.41 Million
1,124,816 Added 41.26%
3,850,920 $3.81 Million
Q2 2024

Aug 07, 2024

BUY
$0.51 - $1.27 $1.11 Million - $2.76 Million
2,170,104 Added 390.31%
2,726,104 $2.45 Million
Q1 2024

May 09, 2024

BUY
$0.8 - $1.51 $220,800 - $416,760
276,000 Added 98.57%
556,000 $656,000
Q4 2023

Feb 07, 2024

BUY
$0.48 - $1.08 $134,400 - $302,400
280,000 New
280,000 $254,000

Others Institutions Holding GOSS

About Gossamer Bio, Inc.


  • Ticker GOSS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,954,000
  • Market Cap $65.8M
  • Description
  • Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...
More about GOSS
Track This Portfolio

Track Monaco Asset Management Sam Portfolio

Follow Monaco Asset Management Sam and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monaco Asset Management Sam, based on Form 13F filings with the SEC.

News

Stay updated on Monaco Asset Management Sam with notifications on news.